Deferred Tax Assets, Gross of ELITE PHARMACEUTICALS INC /NV/ from 31 Mar 2023 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Mar 2023 to 31 Mar 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Deferred Tax Assets, Gross for the quarter ending 31 Mar 2025 was $20,073,000, a 17% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $20,073,000 -$4,220,000 -17% 31 Mar 2025 10-K 30 Jun 2025 2025 FY
Q1 2024 $24,293,000 +$1,687,000 +7.5% 31 Mar 2024 10-K 30 Jun 2025 2025 FY
Q1 2023 $22,606,000 31 Mar 2023 10-K 01 Jul 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.